From FDA, Olmesartan would induce sprue-like enteropathy. The clinical symptoms/signs are long-term sever diarrhea combined with decreased body weight. The condition would be relieved if stopping this medication.
From:
全站熱搜
From FDA, Olmesartan would induce sprue-like enteropathy. The clinical symptoms/signs are long-term sever diarrhea combined with decreased body weight. The condition would be relieved if stopping this medication.
From: